Transdermal Pain Relief Gels
A line of prescription strength gels, providing physicians with options for a personalized pain treatment plan.
  • CONVIENENT, EASY-TO-USE
  • AFFORDABLE
  • AVAILABLE IN TWO FORMULATIONS
  • PRESCRIPTION STRENGTH
  • APPLY DIRECTLY TO AREA OF PAIN
  • A “NO PILL” CHOICE
  • NON-OPIATE, NON-ADDICTIVE
  • FOR OFFICE USE ONLY *
  • MANUFACTURED IN ALBANY, NY AT A 503B OUTSOURCING FACILITY

MyGELforReliefTM is a local pain relief therapy in a concentrated prescription strength treatment applied directly to the affected region. Manufactured to meet growing demand for alternative or additional pain treatments to oral narcotics- opiates, physical therapy, massage or local injection of anesthetics and/or steroids. Pharmaceutic Labs, a CGMP 503B OUTSOURCING FACILITY in Albany, NY upholds FDA standards and is regularly inspected for quality assurance. Our transdermal pain relief gels have the same APIs (Active Pharmaceutical Ingredients) as FDA approved products prescribed as safe and effective medical therapy. 

Contains clinically driven active ingredients with established applications:
  • Diclofenac Sodium, a nonsteroidal anti-inflammatory agent
  • Lidocaine HCl, a local anesthetic
  • Baclofen, a muscle relaxant
  • Ketamine HCl, an analgesic
 
PERIPHERAL PAIN
Irritation to Nerves in the Body 
Osteoarthritis of the knee, foot and hand including Basal Thumb Arthritis
Acute and Chronic Tendon/Ligament Injuries from falls, work or athletic causes
Plantar Fascitis
Lateral and Medial Epicondylitis - Tennis Elbow
Myofascial Pain 
NEUROPATHIC PAIN
Damage to Nerves in the Body 
Diabetic Neuropathy
Post Herpetic Neuralgia
Nerve Damage after accident
Nerve Damage after surgery
Other Causes of Nerve Damage 
PAIN of Spinal and Cranial Origin
 
Herniated Disc
Spinal Stenosis
Degenerative Disc Disease
Tension and Occipital Neuralgia headache
TMJ Syndrome and Trigeminal Neuropathy 
MyGEL for Relief Logo
A new prescription-strength option for physicians preferring non-opiate pain relief for their patients.
Transdermal pain relief gels from Pharmaceutic Labs are designed to be applied locally. They contain multiple agents from different drug classes combined into one multi-modal treatment without the systemic cumulative side effects observed in oral drugs. Multiple drugs with potentially complementary designed mechanisms of actions target multiple pathophysiological processes involved in complex pain. Our transdermal therapies are supported by 80 articles in a Systematic Literature Review. MyGELforReliefTM APIs have been approved as safe and effective medical therapy in other approved medications. They minimize systemic medication side effects and drug-drug Interactions without opiate risks of addiction and dangerous side effects.
All products are made at Pharmaceutic Labs’ 503B OUTSOURCING FACILITY in Albany, NY:
  • following the FDA guidelines 21 CFR 210 and 21 CFR 211, the highest quality regulations for pharmaceuticals
  • raising the level of patient safety through a process-driven quality assurance system
  • requiring all APIs are tested to ensure chemical identification
  • testing every batch for assay and impurities
  • going through a full product validation and stability protocols for all finished products
  • including a Certificate of Analysis signed by the Director of Quality Assurance with every shipment
Quantity (g) #API % API NDC APIs Available
45g 3 12% 69324-138-01 Diclofenac Sodium, Lidocaine HCl, Baclofen U.S.A. except NY
36g 3 12% 69324-138-02 Diclofenac Sodium, Lidocaine HCl, Baclofen New York State
45g 4 16% 69324-139-01 Diclofenac Sodium, Lidocaine HCI, Ketamine HCI, Baclofen Check with sales rep
36g 4 16% 69324-139-02 Diclofenac Sodium, Lidocaine HCI, Ketamine HCI, Baclofen New York State
Quantity (g): 45g #API: 3 % API: 12% NDC: 69324-138-01 APIs: Diclofenac Sodium, Lidocaine HCl, Baclofen Available: U.S.A. except NY
Quantity (g): 36g #API: 3 % API: 12% NDC: 69324-138-02 APIs: Diclofenac Sodium, Lidocaine HCl, Baclofen Available: New York State
Quantity (g): 45g #API: 4 % API: 16% NDC: 69324-139-01 APIs: Diclofenac Sodium, Lidocaine HCI, Ketamine HCI, Baclofen Available: Check with sales rep
Quantity (g): 36g #API: 4 % API: 16% NDC: 69324-139-02 APIs: Diclofenac Sodium, Lidocaine HCI, Ketamine HCI, Baclofen Available: New York State